Herbalife Ltd. (HLF) Q4 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings report shows strong performance in key areas like Adjusted EBITDA, operating cash flow, and debt reduction. Despite some challenges like FX headwinds and regional sales declines in China, the company has demonstrated financial discipline and strategic growth initiatives. The Q&A highlights optimism in future growth, particularly in India, and strategic focus on personalized nutrition. However, lack of detailed guidance for China and minimal contribution from Pro2col slightly temper the outlook. Overall, the positive financial metrics and strategic initiatives are expected to boost the stock price in the short term.
Key Financial Performance
Net Sales (Q4 2025) $1.3 billion, up 6.3% year-over-year. Growth driven by strong performance in India and overall momentum in sales.
Net Sales (Full Year 2025) Over $5 billion, up nearly 1% year-over-year (2.5% excluding FX). Growth attributed to pricing benefits and volume increases.
Adjusted EBITDA (Q4 2025) $156 million, exceeding guidance. Margin at 12.2%, down 20 basis points year-over-year due to FX headwinds and employee bonus accruals.
Adjusted EBITDA (Full Year 2025) $658 million, margin at 13.1%. Marked the second consecutive year of adjusted EBITDA and margin expansion.
Operating Cash Flow (Full Year 2025) $333 million, up 17% year-over-year. Reflects strong cash generation and operational efficiency.
Debt Repayment (2025) $283 million repaid, reducing leverage ratio to 2.8x from 3.9x at the end of 2023. Demonstrates financial discipline and focus on balance sheet strength.
Gross Profit Margin (Q4 2025) 77.5%, down 30 basis points year-over-year. Impacted by FX headwinds, sales mix, and input cost inflation, partially offset by pricing benefits.
Net Income (Q4 2025) $85 million, includes $54 million of noncash deferred tax benefits. Adjusted net income was $48 million.
Adjusted Diluted EPS (Q4 2025) $0.45, includes $0.07 FX headwinds. Benefited from a lower effective tax rate driven by geographic income mix.
Regional Performance (Q4 2025) India: $250 million net sales, up nearly 15% year-over-year. Latin America: 18% growth in reported net sales. EMEA: 9% growth in reported net sales. Asia Pacific: 5% growth in reported net sales. North America: Sales declined less than 1%. China: Net sales down 4%.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
MultiBurn launch: Advanced weight management offering launched in July 2025.
HL/Skin introduction: Expanded skin care portfolio in EMEA with K-beauty formulations and AI-powered facial analysis tool in September 2025.
Life I/O Baseline: Entered the healthy lifespan category in December 2025.
India market growth: Achieved highest quarterly net sales of $250 million in Q4 2025, driven by reduced GST rates and 15% year-over-year growth.
North America distributor growth: Second consecutive quarter of double-digit growth in new distributors, up 19% in Q4 2025.
Latin America growth: Seventh consecutive quarter of year-over-year growth in new distributors.
Debt reduction: Reduced total leverage ratio to 2.8x from 3.9x in 2023, repaying $283 million of debt in 2025.
Pro2col Beta 2.0: Enhanced distributor marketing pages and coach dashboard, expanding beta access to U.S., Canada, Puerto Rico, and select EMEA markets.
Cristiano Ronaldo partnership: Acquired 10% equity stake in HBL Pro2col Software for $7.5 million, enhancing visibility and engagement for personalized nutrition.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Market Conditions: The company faces potential challenges from foreign exchange (FX) headwinds, which impacted gross profit margin by 100 basis points in Q4 2025. Additionally, economic uncertainties in key markets like China, where net sales declined by 4% year-over-year, could pose risks to future performance.
Regulatory Hurdles: The company incurred an $11 million transition charge related to changes in India's GST amendments in September 2025. This regulatory change also impacted the company's ability to fully utilize certain input GST credits.
Supply Chain and Cost Pressures: Input cost inflation and unfavorable sales mix negatively impacted gross profit margin by 30 basis points each in Q4 2025. Lower absorption rates also contributed to cost pressures.
Strategic Execution Risks: The phased rollout of the Pro2col digital platform, while strategic, carries risks related to integration and adoption by distributors. Feedback from beta testing indicates ongoing refinements are needed to meet real-world needs.
Competitive Pressures: The company operates in a highly competitive health and wellness market, which requires continuous innovation and investment in new products and digital tools to maintain market share.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Revenue Growth: For the first quarter of 2026, Herbalife expects net sales growth of 3% to 7% year-over-year on a reported basis, including a 250 basis point tailwind from currency. On a constant currency basis, net sales growth is projected to be 0.5% to 4.5% year-over-year. For the full year 2026, reported net sales growth is expected to be 1% to 6% year-over-year, with a 100 basis point tailwind from currency. On a constant currency basis, net sales are expected to be flat to up 5% year-over-year.
Adjusted EBITDA: For the first quarter of 2026, adjusted EBITDA is expected to range between $155 million and $175 million on both a reported and constant currency basis. For the full year 2026, adjusted EBITDA is projected to be between $670 million and $710 million on a reported basis, or $665 million to $705 million on a constant currency basis.
Capital Expenditures: Planned capital expenditures for the first quarter of 2026 are expected to range from $10 million to $20 million. For the full year 2026, capital expenditures are projected to be between $50 million and $80 million. Additionally, capitalized SaaS implementation costs are expected to range from $40 million to $60 million, incremental to CapEx.
Tax Rate: For the full year 2026, the adjusted effective tax rate is expected to be approximately 30%.
Debt Reduction: Herbalife remains committed to reducing its gross debt to $1.4 billion by the end of 2028.
Product Innovation and Personalization: In 2026, Herbalife plans to launch new innovative products to modernize and expand its portfolio. The company will also introduce personalized nutritional supplements leveraging data and insights, with U.S. distributors in the Pro2col beta group gaining first access by the end of the first half of 2026.
Digital Transformation: The Pro2col health and wellness operating system will continue its phased beta rollout, expanding to select EMEA markets in 2026. This system aims to enhance distributor engagement and customer support through data-driven personalization.
Regional Performance: North America is expected to deliver full-year net sales growth in 2026.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Can you provide guidance on sales for different geographic segments in 2026, especially considering strong India results and GST impact?
A:Management expects net sales growth in every region except China, which is expected to recover in 2027. No detailed regional guidance was provided.
Q:What are the expectations for the Pro2col program's sales contribution and EBITDA margin expansion in 2026?
A:Pro2col is in the beta phase with minimal top-line contribution expected in 2026. EBITDA margin expansion is guided at 20-30 bps, with a $16 million GST-related cost in India slightly dragging margins.
Q:What drove the growth in the energy, sports, and fitness product category in 2025, and how will it continue in 2026?
A:The category has consistently outpaced overall company performance, with contributions from targeted nutrition and sports products. Growth was supported by launches in India and Nutrition Clubs with products like Liftoff.
Q:Can you provide details on expanding Nutrition Club infrastructure in Europe, Middle East, and Africa?
A:The Breakfast Budget Clubs model, originating in the UK, is expanding to other markets through biannual master classes. The model emphasizes daily community interaction and product use.
Q:What contributed to positive sales leader retention rates in North America and Latin America in 2025?
A:Retention improvements are attributed to training programs like Mastermind, better education, and key account management programs. The overall strategy and support for sales leaders have made a difference.
Q:How much did new product launches contribute to sales growth in 2025?
A:Successful launches like MultiBurn in North America and HL/Skin in EMEA significantly contributed to sales growth. The company has improved its product launch effectiveness.
Q:What is the expectation for distributor events in 2026?
A:Event costs are expected to increase slightly more than sales growth. The number and size of events will depend on regional needs, with a focus on increasing attendance.
Q:How does the company plan to align its evolving product portfolio with its customer base?
A:The company aims to attract more sophisticated customers while supporting its existing base. It plans to expand personalized solutions and leverage its community of distributors to deliver tailored health and wellness solutions.
Q:What is the impact of the reduced GST rate in India on sales and margins?
A:The reduced GST rate is expected to be a tailwind until late 2026, driving volume growth. However, it results in a $16 million incremental cost, slightly dragging margins.
Q:What is the relationship between distributor growth and member growth?
A:Distributor recruiting has been emphasized through programs like Herbalife Premier League, while preferred customer growth varies by market. Both remain important for the business.
Q:Is the company shifting its strategy with acquisitions and equity partnerships?
A:The company is focusing on small acquisitions and partnerships that align with its platform vision, such as personalized nutrition and technology. These efforts aim to enhance its core business and distributor network.
Q:Review of Unclear Management Responses
A:Management avoided providing detailed regional sales guidance beyond stating growth expectations for all regions except China. Additionally, they did not provide specific sales contributions for Pro2col or a detailed breakdown of product category growth by market.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
AI analysis
AI community
America digit
Banyas Vice
Baseline launch
Beta enhancement
CEO today
Canada Puerto
Central health
EMEA edge
EMEA market
HBL Software
Herbalife Ltd
Herbalife awareness
Herbalife subsidiary
Herbalife term
India outperformance
Life Baseline
Ltd Instructions
MultiBurn skin
Officer Chief
Rico EMEA
Skin EMEA
Software Herbalife
ability discipline
access supplement
adoption year
analysis tool
announcement today
approach reach
audience distributor
availability access
beta group
insight
partner
platform vision
product portfolio
sale India
success
HLF Transcript
Herbalife Ltd. (HLF) Q4 2025 Earnings Call Transcript
Positive2-19
The earnings report shows strong performance in key areas like Adjusted EBITDA, operating cash flow, and debt reduction. Despite some challenges like FX headwinds and regional sales declines in China, the company has demonstrated financial discipline and strategic growth initiatives. The Q&A highlights optimism in future growth, particularly in India, and strategic focus on personalized nutrition. However, lack of detailed guidance for China and minimal contribution from Pro2col slightly temper the outlook. Overall, the positive financial metrics and strategic initiatives are expected to boost the stock price in the short term.
Herbalife Ltd. (HLF) Presents at Bank of America Leveraged Finance Conference Transcript
Neutral12-2
Herbalife Ltd. (HLF) Q3 2025 Earnings Call Transcript
Positive11-5
The company has shown positive financial performance with debt reduction, regional sales growth, and promising product launches. The Q&A session highlighted strong engagement and feedback for new products, with no anticipated increase in SG&A costs. The raised guidance and strategic focus on subscription revenue and new product lines further support a positive outlook. Despite some lack of detail on profitability differences, overall market sentiment appears optimistic, suggesting a positive stock price movement.
Herbalife Ltd. (HLF) Presents At Barclays 18th Annual Global Consumer Staples Conference 2025 Transcript
Neutral9-2
HLF Slides
HLF Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
